Results 121 to 130 of about 1,111,865 (207)

Correction: García-Delgado et al. Translational Insights into Interferon Alpha's Effects on Immunomolecular Dynamics in Philadelphia-Negative Myeloproliferative Neoplasms. <i>Cancers</i> 2025, <i>17</i>, 2273. [PDF]

open access: yesCancers (Basel)
García-Delgado R   +7 more
europepmc   +1 more source

[Case report of human myiasis caused by Cochliomyia hominivorax in Mexico]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Hernández-Peláez DK   +2 more
europepmc   +1 more source

[Primary aldosteronism in resistant hypertension unmasked by a thiazide-induced severe hypokalaemia]. [PDF]

open access: yesAn Sist Sanit Navar
Del Rey Fernández AJ   +2 more
europepmc   +1 more source

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes. [PDF]

open access: yesLiver Int
Del Barrio M   +38 more
europepmc   +1 more source

Safety recommendations on laboratory and blood count values for early mobilization in critically ill adults: an expert consensus. [PDF]

open access: yesCrit Care Sci
Popayan AME   +23 more
europepmc   +1 more source

Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial. [PDF]

open access: yesAm J Hematol
Bernal T   +29 more
europepmc   +1 more source

[Gonococcal arthritis: neither so common nor so straightforward. Clinical description of cases diagnosed in northern Spain between 2013 and 2023]. [PDF]

open access: yesRev Esp Quimioter
Guio Carrión L   +12 more
europepmc   +1 more source

Case Report: Central nervous system relapse treated with elranatamab after prior BCMA and GPRC5D directed therapies in relapsed/refractory multiple myeloma. [PDF]

open access: yesFront Oncol
Pérez-Calle R   +10 more
europepmc   +1 more source

[XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part I)]. [PDF]

open access: yesRev Neurol
Fernández Ó   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy